What drives innovation? : lessons from COVID-19 R&D
Year of publication: |
February 2021
|
---|---|
Authors: | Agarwal, Ruchir ; Gaulé, Patrick |
Publisher: |
[Washington, DC] : International Monetary Fund |
Subject: | COVID-19 | Innovation | Market Size | Pharmaceutical Industry | Coronavirus | Pharmaindustrie | Pharmaceutical industry | Innovationsmanagement | Innovation management | Arzneimittel | Pharmaceuticals | Wirkungsanalyse | Impact assessment |
Extent: | 1 Online-Ressource (circa 59 Seiten) Illustrationen |
---|---|
Series: | IMF working papers. - Washington, DC : IMF, ZDB-ID 2108494-4. - Vol. WP/21, 48 |
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Graue Literatur ; Non-commercial literature ; Arbeitspapier ; Working Paper |
Language: | English |
ISBN: | 978-1-5135-7006-8 |
Other identifiers: | 10.5089/9781513570068.001 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
What drives innovation? : lessons from COVID-19 R&D
Agarwal, Ruchir, (2021)
-
What drives innovation? : lessons from COVID-19 R&D
Agarwal, Ruchir, (2022)
-
COVID-19 vaccines and the role of patents
Larson, Kelli, (2021)
- More ...
-
Why U.S. immigration matters for the global advancement of science
Agarwal, Ruchir, (2021)
-
Why U.S. immigration barriers matter for the global advancement of science
Agarwal, Ruchir, (2021)
-
Invisible geniuses: could the knowledge frontier advance faster?
Agarwal, Ruchir, (2018)
- More ...